Propensity score-matching analysis of local consolidative therapy for patients with oligometastatic non-small cell lung cancer without progression after front-line systemic therapy

被引：0
|
作者：
Zhang, J-T. [1 ]
Liu, S-Y. [1 ]
Lin, J-T. [1 ]
Yan, H-H. [1 ]
Yang, X. N. [1 ]
Wu, Y-L. [1 ]
Zhong, W-Z. [1 ]
机构：
[1] Guangdong Gen Hosp, Dept Pulm, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
444P
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
    Deng, Jiayi
    Yang, Mingyi
    Zhou, Qing
    CANCER BIOLOGY & MEDICINE, 2025, 22 (01) : 21 - 27
  • [12] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer
    Panje, C. M.
    Dedes, K. J.
    Matter-Walstra, K.
    Schwenkglenks, M.
    Gautschi, O.
    Siano, M.
    Aebersold, D. M.
    Plasswilm, L.
    Lupatsch, J. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (06) : 588 - 588
  • [13] Efficacy of local therapy for patients with oligometastatic non-small cell lung cancer
    Sato, Y.
    Fujimoto, D.
    Hosoya, K.
    Kawachi, H.
    Hamakawa, H.
    Takahashi, Y.
    Kokubo, M.
    Hara, S.
    Tomii, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [14] Bevacizumab with docetaxel and carboplatin as front-line therapy for non-small cell lung cancer
    Kim, Edward S.
    Ghelani, Dipak
    Kies, Merrill S.
    Blumenschein, George, Jr.
    ANNALS OF ONCOLOGY, 2006, 17 : 234 - 234
  • [15] Correlative analysis of systemic markers from a randomized trial assessing local consolidative therapy for non-small cell lung cancer (NSCLC) patients with oligometastatic disease
    Tang, Chad
    Heymach, John V.
    Reuben, Alexandre
    Tran, Hai
    Welsh, James
    Wargo, Jennifer
    Liao, Zhongxing
    Tsao, Anne
    Prado, Eric
    Swisher, Stephen
    Zhang, Jianjun
    Gomez, Daniel
    CANCER RESEARCH, 2017, 77
  • [16] Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment
    Yang Ni
    Xin Ye
    Xia Yang
    Guanghui Huang
    Wenhong Li
    Jiao Wang
    Xiaoying Han
    Zhigang Wei
    Min Meng
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 197 - 203
  • [17] A meta-analysis of front-line therapy of osimertinib in treating non-small cell lung cancer
    Zhao, Qian
    Chen, Yunfeng
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [18] Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment
    Ni, Yang
    Ye, Xin
    Yang, Xia
    Huang, Guanghui
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    Wei, Zhigang
    Meng, Min
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) : 197 - 203
  • [19] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
    Panje, Cedric M.
    Dedes, Konstantin J.
    Matter-Walstra, Klazien
    Schwenkglenks, Matthias
    Gautschi, Oliver
    Siano, Marco
    Aebersold, Daniel M.
    Plasswilm, Ludwig
    Lupatsch, Judith E.
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 257 - 263
  • [20] Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer
    Miller, Douglas A.
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 611 - +
12345